The testosterone cypionate shortage that started in early 2023 is still not resolved. As of April 2026, the American Society of Health-System Pharmacists (ASHP) continues to list T-cypionate injection as intermittently available, with major manufacturer back orders and missed release estimates. If your retail pharmacy has told you "we can't get it this month," you're not imagining things, and you're not alone.
The good news: there are multiple working alternatives, and most TRT patients can switch with zero change in how they feel, if their prescriber moves quickly.
Key Takeaways
- T-cypionate remains on the ASHP shortage list in April 2026 -- Hikma's late-January release estimate has passed without resolution
- Testosterone enanthate is pharmacokinetically equivalent and the simplest swap at the same weekly dose
- Compounded testosterone cypionate from PCAB-accredited 503A pharmacies is legal, legitimate, and widely used by online TRT clinics
- Topical gels (generic 1.62%) are the most widely available fallback but require daily application
- Online TRT clinics have been largely insulated from the shortage because they source through compounding, not retail pharmacies
What the Shortage Actually Looks Like Right Now
The shortage is not a total blackout. It's intermittent availability, which is actually worse in some ways -- you can fill one month and then get told "sorry, we don't have it" the next.
Current Manufacturer Status
| Manufacturer |
Product |
Status (April 2026) |
| Hikma |
T-cypionate 200 mg/mL, 10 mL vials |
On back order; missed late-January 2026 release estimate |
| Pfizer |
Depo-Testosterone 100 mg/mL, 10 mL vials |
On back order, no release date |
| Pfizer |
Depo-Testosterone 200 mg/mL, 10 mL vials |
On back order, no release date |
| Pfizer |
Depo-Testosterone 200 mg/mL, 1 mL vials |
Limited weekly allocations |
| Pfizer |
T-cypionate 100 mg/mL, 10 mL vials |
Limited supply, weekly releases |
The 200 mg/mL concentration has been slightly more available than 100 mg/mL. If your prescription specifies 100 mg/mL, ask your prescriber whether switching to 200 mg/mL (with adjusted volume) is possible -- it often is, and it opens up more supply.
Why This Is Still Happening in 2026
Three drivers have kept the shortage going:
- Demand keeps climbing. Telehealth TRT prescribing has grown fast, and FDA signals around descheduling and expanded indications have further normalized treatment. Meanwhile, FDA expansion of TRT for low libido in idiopathic hypogonadism is set to widen the prescribing pool even more.
- DEA production quotas. Because testosterone is still a Schedule III controlled substance, the DEA caps annual manufacturing quotas. Quotas haven't kept pace with real demand.
- Manufacturing consolidation. Only a handful of manufacturers produce injectable testosterone cypionate. When one experiences a delay, there's limited slack in the system.
Your Five Realistic Alternatives
If your pharmacy can't fill your T-cypionate prescription, you have five practical paths. Ranked roughly by how close they stay to your current protocol:
1. Testosterone Enanthate (Cleanest Swap)
How it compares: Cypionate and enanthate are both long-acting esters with half-lives of 7-8 days and nearly identical pharmacokinetics. The blood-level curves between the two are effectively indistinguishable in practice.
Dose conversion: 1:1. If you're on 120 mg cypionate weekly, you move to 120 mg enanthate weekly.
Availability: Enanthate has also had intermittent shortages during 2023-2025, but supply is currently more reliable than cypionate as of Q2 2026.
Cost: Generic enanthate with a GoodRx-style coupon runs $14-35/month, similar to cypionate. Insurance usually covers it the same way.
Protocol impact: None. Keep your injection frequency and site rotation the same. If you want a detailed walkthrough of the differences, see our cypionate vs. enanthate comparison.
2. Compounded Testosterone Cypionate (Most Common Online-Clinic Solution)
How it compares: Chemically identical to commercial T-cypionate. The active ingredient (testosterone cypionate USP) is compounded in a sterile facility at the concentration and volume specified by your prescription.
Legitimacy: Fully legal when dispensed by a PCAB-accredited 503A pharmacy against a patient-specific prescription. This is how most online TRT clinics source medication regardless of the shortage.
What to verify:
- Pharmacy is licensed in your state
- PCAB accreditation or equivalent compounding certification
- Certificate of Analysis (COA) available on request
- Clear labeling with compounding date and beyond-use date
Cost: Typically $40-90/month for a 10 mL vial. Not usually covered by insurance, but the cash price is often close to or below your commercial copay.
Protocol impact: None. Most compounders offer 200 mg/mL concentrations in either grapeseed or cottonseed oil.
3. Testosterone Gel (Most Widely Available)
How it compares: Topical 1.62% testosterone gel (generic formulation) produces steadier serum levels with less peak/trough fluctuation than injections, but requires daily application and has a transfer risk to partners and children through skin contact.
Dose conversion: Not 1:1 with injections. Typical starting doses are 20.25-40.5 mg/day for the 1.62% gel (1-2 pumps), titrated based on 2-4 week labs.
Availability: Generally available nationwide as of April 2026. Generic versions have held up through the injectable shortage.
Cost: Generic 1.62% gel is typically tier 2 on most formularies -- $40-80/month with insurance, $150-300/month cash.
Protocol impact: Significant. Daily application replaces weekly or twice-weekly injections. Expect an adjustment period and a lab check at 4-6 weeks.
4. Testosterone Patches (Androderm)
How it compares: Transdermal patches deliver testosterone continuously over 24 hours. More stable than injections but with higher rates of skin irritation.
Availability: Androderm itself has had its own supply problems. Check with your pharmacy before committing to this route.
Cost: $200-500/month. Often tier 2 or 3 on insurance.
Protocol impact: Daily patch application, rotation of application sites, and skin-irritation management.
5. Oral Testosterone Capsules (Jatenzo, Tlando, Kyzatrex)
How it compares: Twice-daily oral testosterone undecanoate capsules taken with food. Bypasses first-pass liver metabolism through lymphatic absorption.
Availability: Available but brand-name only -- no generic yet.
Cost: $500-900/month. Rarely covered well by insurance, often non-formulary.
Protocol impact: Daily pills with food, plus more frequent early lab monitoring. Not a good fit for price-sensitive patients. See our detailed breakdown of oral testosterone options.
What to Actually Do This Week If You're Running Low
The biggest risk from the shortage isn't permanent disruption -- it's a short gap in therapy that causes symptom rebound while your prescriber scrambles.
The 72-Hour Action Plan
Day 1:
- Call your pharmacy and ask whether they have current stock of 200 mg/mL cypionate (any manufacturer), enanthate (any manufacturer), or either in 1 mL vial format.
- Call 2-3 other pharmacies within driving distance with the same questions. Chain pharmacies (CVS, Walgreens) draw from the same wholesaler pool; try an independent or compounding pharmacy for a different supply chain.
Day 2:
- Message your prescriber with what you found. If nothing is available locally, ask for (a) a new prescription written for testosterone enanthate at your current weekly dose, or (b) a new prescription routed to a 503A compounding pharmacy they've verified.
- If you use a retail pharmacy and your prescriber can't route to a compounder, consider switching to an online TRT clinic that sources through compounding.
Day 3:
- Place the new prescription. Most compounding pharmacies ship within 2-5 business days; most retail pharmacies can confirm fill status within 24 hours.
- If you anticipate a gap of more than 7 days, talk to your prescriber about a short topical-gel bridge rather than missing doses.
Do Not Do This
- Don't ration your existing vial by skipping doses or stretching your protocol. Inconsistent dosing produces worse symptoms than a planned short gap and can mess up your next labs.
- Don't buy testosterone from "research chemical" websites or gray-market sellers. These are unregulated, frequently mislabeled, and can put you in legal jeopardy given testosterone's Schedule III status.
- Don't stop therapy cold turkey without telling your prescriber. Abrupt cessation produces withdrawal symptoms (fatigue, low mood, low libido) that can take 4-8 weeks to stabilize. If you do have to come off temporarily, see our guide to coming off TRT for what to expect.
Why Online TRT Clinics Have Been Insulated From the Shortage
A recurring pattern during this shortage: patients using online TRT clinics have mostly been unaffected, while patients using retail pharmacies have faced repeated disruption.
The reason is sourcing. Most online TRT clinics have long-standing relationships with 503A compounding pharmacies rather than wholesale supply chains. Compounding pharmacies purchase bulk testosterone cypionate USP powder, not finished commercial vials, which means they aren't dependent on Hikma or Pfizer release schedules. Their supply is tied to the underlying DEA quota, but the bottleneck has been final-stage commercial manufacturing rather than raw material.
If you've been going through insurance and a retail pharmacy and this shortage has been a recurring headache, a cash-pay online clinic sourcing through a compounder is usually $75-150/month all-in (medication + visit + labs at renewal). That's often not much more than a copay plus gas money. We walk through the math in our guide to TRT with insurance vs. without and what you should actually pay for TRT.
Will the Shortage End in 2026?
Unclear, and the honest answer is "probably not fully." Three things would need to change for reliable commercial supply to return:
- DEA quota increases. Until the DEA raises annual quotas or testosterone is descheduled, the upstream supply is capped regardless of manufacturing capacity.
- Manufacturer expansion. At least one more manufacturer would need to enter the injectable T-cypionate market, or Hikma and Pfizer would need to expand capacity.
- Demand stabilization. Telehealth prescribing growth would need to flatten. Current trends point the other direction, especially if the FDA's idiopathic hypogonadism indication expansion is approved.
Realistically, expect intermittent availability through at least late 2026. The practical takeaway: if you're starting TRT now, don't plan around retail pharmacy cypionate supply. Build your protocol around enanthate, a compounded product, or a clinic that sources through compounding from the start.
Bottom Line
The T-cypionate shortage is a solvable problem, not an emergency. Enanthate is an identical-feeling swap at the same dose. Compounded testosterone is legal, legitimate, and how most online clinics already operate. Topical gels are a widely available fallback if you need one fast.
The only real risk is a gap in therapy while you're figuring out a plan. If your pharmacy just told you they can't fill your prescription, start the 72-hour action plan today. If you're already on TRT through an online clinic and haven't felt any of this, that's why.
References
- American Society of Health-System Pharmacists. Drug Shortage Detail: Testosterone Cypionate Injection. ASHP Drug Shortages Database, accessed April 2026.
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107-117.
- FDA. Drug Shortages: Testosterone Cypionate Injection. FDA CDER Drug Shortage Staff, 2026.
- Pharmacy Compounding Accreditation Board (PCAB). 503A Pharmacy Standards, 2024 update.
- Ryan Haight Online Pharmacy Consumer Protection Act, 21 U.S.C. 829(e) -- telehealth prescribing of controlled substances.
- DEA. Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for List I Chemicals for Calendar Year 2026.